Pressure on the Appointed Actuary at valuation sign-off
The Appointed Actuary of a mid-sized insurer is finalising the statutory valuation. The chief executive asks him to reduce the incurred-but-not-reported reserve and to adopt a mortality table with 6% lower qx for the term portfolio, arguing that recent reinsurance experience supports it. The two changes together would lift the solvency ratio from 1.42 to 1.58, above the 1.50 regulatory minimum, and would permit a ₹120 crore dividend to the shareholder. The actuary's own analysis shows the recent experience is credible only for ages 25–40 and covers 14 months, with a 95% confidence interval that includes the current table. The peer review actuary has flagged the proposed IBNR as 30% below his estimate. The chief executive notes that the actuary's contract renewal is due in three months and that dividend guidance has already been given to analysts.
1. Identify the professional and ethical issues and the standards that bear on them.
Read the worked answer
Core issue. The actuary is being asked to certify a valuation basis that the evidence does not support, in order to produce a solvency ratio and a dividend. That is a conflict between commercial pressure and the actuary's duty to policyholders, the regulator and the profession.
Specific problems.
- Lower qx: 14 months of data confined to ages 25–40 is not credible across the whole term portfolio, and the confidence interval includes the current table. Selecting a 6% reduction is therefore not evidence-based.
- IBNR: a 30% gap against the peer reviewer's estimate is a material disagreement, not a rounding difference. The actuary must be able to justify his figure claim by claim and method by method.
- Solvency: a ratio of 1.42 is already below the 1.50 minimum. The real issue is a capital shortfall, not an assumption choice. A dividend of ₹120 crore while below the minimum would not be permissible and may breach the regulator's distribution rules.
- Inducement: the mention of contract renewal is a clear intimidation threat.
Standards. The IAI Code of Conduct (integrity, objectivity, professional competence, confidentiality, professional behaviour) and the professional standards and guidance for Appointed Actuaries, including the requirement to act independently and to report the basis of the valuation. The actuary must also comply with the regulator's appointed-actuary regulations and any peer review requirements. The peer review finding should be documented and resolved before sign-off, not overridden by management.
2. What should the actuary do, in sequence, and when should he escalate?
Read the worked answer
Step 1 - hold the line. Decline to change the qx or the IBNR without adequate evidence, and explain why in writing. Offer to review the mortality assumption once credible data across the full age range and a longer period are available.
Step 2 - propose the legitimate route. The gap to 1.50 should be closed by capital injection, reinsurance, or reduced new-business strain, not by assumption changes. Present the board with the capital requirement and the alternatives, including the effect of a 1.50 ratio on the dividend.
Step 3 - document. Record the request, the actuarial evidence, the peer review finding and the advice given, contemporaneously. Ask for the peer reviewer's report in writing.
Step 4 - escalate. If the chief executive persists, raise the matter with the audit committee or the board, and confirm the position in the Appointed Actuary's report. If the board still directs an unsupported basis, the actuary should refuse to sign the valuation and report the matter to the regulator, having taken advice on confidentiality and legal obligations.
Step 5 - resignation. If the insurer proceeds without his sign-off or instructs him to certify a basis he cannot support, resign and set out the reasons in writing to the board and, where appropriate, the regulator. Contract renewal is irrelevant to the decision; accepting the pressure would make the actuary complicit and expose him to disciplinary action.
3. How should the actuary handle communication with the board, the regulator and the analysts' dividend guidance?
Read the worked answer
Board. Provide a short, factual paper: the current solvency ratio, the capital required to reach 1.50, the effect of the proposed assumption changes, the peer review finding, and the actuary's opinion that the changes are not supportable. State clearly that a ₹120 crore dividend cannot be recommended while solvency is below the minimum. Give the board a decision record showing who decided what.
Regulator. File the statutory valuation on a supportable basis, with the disagreement and the peer review conclusion disclosed. If the board overrides the actuary, the regulator should hear it from the actuary first, not from a later supervisory review. Use the Appointed Actuary's report to set out the basis, the sensitivities and the capital position.
Analysts' guidance. This is a board and investor-relations matter, not the actuary's, but the actuary should make clear in writing that the dividend assumption in the guidance is not supported. The company may need to correct market expectations; continuing to guide a dividend that cannot lawfully be paid creates a disclosure risk that goes well beyond the actuarial valuation.
Tone. The communication should be calm and evidence-based, avoiding personal accusations. The actuary's duty is to give the board the correct picture, not to win an argument. If the board accepts the position, record the corrected plan - capital raise, reinsurance or product repricing - and monitor it quarterly.